Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1111
https://www.valueinhealthjournal.com/article/S1098-3015(16)32477-9/fulltext
Title : Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line For The Management of Rheumatoid Arthritis In Greece
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32477-9&doi=10.1016/j.jval.2016.09.1111
First page : A538
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1040
Categories :
Tags :
Regions :
ViH Article Tags :